"10.1371_journal.pone.0104082","plos one","2014-08-05T00:00:00Z","Maria Sabater-Lleal; Anders Mälarstig; Lasse Folkersen; María Soler Artigas; Damiano Baldassarre; Maryam Kavousi; Peter Almgren; Fabrizio Veglia; Guy Brusselle; Albert Hofman; Gunnar Engström; Oscar H Franco; Olle Melander; Gabrielle Paulsson-Berne; Hugh Watkins; Per Eriksson; Steve E Humphries; Elena Tremoli; Ulf de Faire; Martin D Tobin; Anders Hamsten","Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Pfizer Worldwide Research and Development, Cambridge, United Kingdom; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom; National Institute for Health Research, Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, United Kingdom; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy; Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Cattere Scientifico, Milan, Italy; Department of Epidemiology, Erasmus Medical Center - University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Clinical Sciences, Lunds University, Malmö, Sweden; Department of Internal Medicine, Erasmus Medical Center - University Medical Center Rotterdam, Rotterdam, the Netherlands; Inspectorate for Health Care, The Hague, the Netherlands; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden; Cardiovascular Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Cardiovascular Medicine and the Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Center for Cardiovascular Genetics, Institute of Cardiovascular Science, University College London, London, United Kingdom; Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden","Conceived and designed the experiments: MS-L AM MSA MDT A. Hamsten. Analyzed the data: MS-L LF MSA DB MK PA FV. Contributed reagents/materials/analysis tools: GB AH GE OHF OM GPB HW PE SEH ET UdF. Contributed to the writing of the manuscript: MS-L AM MSA DB GE SEH MDT A. Hamsten. Performed statistical analyses: A. Hofman.","With regards to conflicts of interest, the authors have the following interests. Anders Mälarstig is employed by Pfizer Worldwide Research and Development and holds Pfizer stocks and options. Dr. Engström has disclosed being formerly employed by AstraZeneca R&D. Dr. Folkersen is currently employed at Novo Nordisk A/S, Denmark although all his contributions in this manuscript were done when employed at Karolinska Institutet. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","08","Maria Sabater-Lleal","MSL",21,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
